Aradigm Awarded NIH Grant to Investigate the Treatment of Pulmonary Non-Tuberculous Mycobacterial (PNTM) Infections ... The National Institute of Allergy and Infectious Diseases , National Institutes of Health , awarded Aradigm Corporation a Small Business Initiative Research grant to investigate the treatment of pulmonary non-tuberculous mycobacteria infections with Aradigm’s inhaled liposomal ciprofloxacin products Pulmaquin® and Lipoquin®.
Aug. 1, 2013 - Business Wire via Yahoo! Finance